TABLE 2.
No. of days after infection | No. of infected lungs/total no. of lungs per treatment group
|
||
---|---|---|---|
PBS | Azithromycin | Azithromycin + rifampin | |
10 | 15/15 | 18/18 | 15/16 |
14 | 14/14 | 17/17 | 13/15 |
20 | 6/14 | 6/19 | 3/16 |
Total | 35/43 | 41/54 | 31/47 |
No. of days after infection | No. of infected lungs/total no. of lungs per treatment group
|
||
---|---|---|---|
PBS | Azithromycin | Azithromycin + rifampin | |
10 | 15/15 | 18/18 | 15/16 |
14 | 14/14 | 17/17 | 13/15 |
20 | 6/14 | 6/19 | 3/16 |
Total | 35/43 | 41/54 | 31/47 |